Checkpoint kinase‑1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repairZhuoyi Fan, Jun Xu|Oncology Reports|2020Cited by 17